Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

Share Price is delayed by 15 minutes
Get Live Data
563.50    -9.50 (-1.66%)
Bid:
562.50
Ask:
563.50
Spread: 1.00 (0.178%)
Market Cap: £1.42b
YCA Live PriceLast checked at - London Stock Exchange

Intraday Yellow Cake Share Chart

Completion of Buyback Programme

9 May 2022 07:00

RNS Number : 7032K
Yellow Cake PLC
09 May 2022
 

09 May 2022

 

 

Yellow Cake plc ("Yellow Cake" or the "Company") 

 

Completion of Buyback Programme

 

Yellow Cake, a specialist company operating in the uranium sector with a view to holding physical uranium for the long term, is pleased to announce that following the purchase of ordinary shares on 6 May 2022, the Company's share buyback programme ("the Programme"), as announced on 4 April 2022, has been completed.

Under the Programme, between 4 April and 6 May 2022, the Company has repurchased in aggregate 566,833 ordinary shares of £0.01 pence each in the Company ("Ordinary Shares") for a total consideration of US$3 million, at a volume weighted average price of 415.4 pence per share and a volume weighted average discount to net asset value of 10.4%.

The Company has 187,740,730 ordinary shares of £0.01 each in issue, of which 4,636,331 ordinary shares are held in treasury. Therefore, the total number of ordinary shares carrying voting rights is 183,104,339.

 

Andre Liebenberg, CEO of Yellow Cake, said:

"This buyback programme has enabled us to acquire additional exposure to uranium per share at below the spot price, thereby creating further value for our shareholders. Our decision to conduct this programme was driven by our continued confidence in the longer term outlook for uranium. This confidence is centred on the consistent supply demand characteristics of constrained supply, and growing demand, with the ever increasing importance of the role of nuclear in our future energy mix, a key dynamic of our investment case."

 

ENQUIRIES: 

 

Yellow Cake plc

Andre Liebenberg, CEO

Carole Whittall, CFO

Tel: +44 (0) 153 488 5200

Nominated Adviser and Joint Broker: Canaccord Genuity Limited

Henry Fitzgerald-O'Connor

James Asensio

Gordon Hamilton

Tel: +44 (0) 207 523 8000

Joint Broker: Berenberg

Matthew Armitt

Jennifer Wyllie

Detlir Elezi

Tel: +44 (0) 203 207 7800

Financial Adviser: Bacchus Capital Advisers

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

Investor Relations: Powerscourt

Peter Ogden

Molly Melville

Tel: +44 (0) 7793 858 211

ABOUT YELLOW CAKE

Yellow Cake is a London-listed company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through the acquisition of uranium royalties and streams or other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 15.83 million lb of U3O8, all of which is held in storage in Canada and France. 

 

FORWARD LOOKING STATEMENTS

Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGKGRNGZZZ
Date   Source Headline
27th Apr 20267:00 amRNSQUARTERLY OPERATING UPDATE
23rd Apr 202610:17 amRNSTR-1: Notification of Major Holdings
7th Apr 20268:42 amRNSTR-1: Notification of Major Holdings
31st Mar 20268:33 amRNSTR-1: Notification of Major Holdings
30th Mar 202612:53 pmRNSTR-1: Notification of Major Holdings
18th Mar 20267:00 amRNSTR-1: Notification of Major Holdings
17th Mar 20267:00 amRNSDelivery and Additional Purchase of Uranium
17th Mar 20267:00 amRNSDelivery and Additional Purchase of Uranium
5th Mar 20263:36 pmRNSTR-1: Notification of Major Holdings
4th Mar 20267:00 amRNSTR-1: Notification of Major Holdings
26th Feb 20267:29 amRNSTR-1: Notification of Major Holdings
19th Feb 20267:00 amRNSTR-1: Notification of Major Holdings
12th Feb 20267:00 amRNSRESULTS OF PLACING
11th Feb 20265:29 pmRNSProposed Uranium Purchase and New Share Placing
4th Feb 20262:17 pmRNSTR-1: Notification of Major Holdings
30th Jan 20264:14 pmRNSTR-1: Notification of Major Holdings
30th Jan 20267:00 amRNSQUARTERLY OPERATING UPDATE
23rd Jan 20267:00 amRNSTR-1: Notification of Major Holdings
21st Jan 20267:00 amRNSTR-1: Notification of Major Holdings
20th Jan 20267:00 amRNSTR-1: Notification of Major Holdings
14th Jan 20266:23 pmRNSTR-1: Notification of Major Holdings
10th Dec 20252:33 pmRNSTR-1: Notification of Major Holdings
10th Dec 20252:27 pmRNSTR-1: Notification of Major Holdings
9th Dec 20257:00 amRNSTR-1: Notification of Major Holdings
4th Dec 20257:00 amRNSInterim Financial Report
13th Nov 20255:24 pmRNSTR-1: Notification of Major Holdings
13th Nov 20257:00 amRNSTR-1: Notification of Major Holdings
13th Nov 20257:00 amRNSTR-1: Notification of major holdings
28th Oct 20257:00 amRNSQuarterly Operating Update
21st Oct 20251:16 pmRNSTR-1: Notification of Major Holdings
7th Oct 20257:00 amRNSTR-1: Notification of Major Holdings
2nd Oct 20254:22 pmRNSTR-1: Notification of Major Holdings
30th Sep 20256:13 pmRNSTR-1: Notification of Major Holdings
24th Sep 20255:00 pmRNSRESULTS OF PLACING
24th Sep 20257:00 amRNSProposed Uranium Purchase and New Share Placing
4th Sep 202510:44 amRNSResults of 2025 Annual General Meeting
29th Aug 20257:00 amRNSStandard form for notification of major holdings
12th Aug 20257:00 amRNSGrant of Awards Under Long Term Incentive Plan
30th Jul 20257:00 amRNSQuarterly Operating Update
29th Jul 202511:45 amRNSTR-1: Notification of Major Holdings
29th Jul 20257:00 amRNSNotice of Annual General Meeting
25th Jul 20257:00 amRNSTR-1: Notification of Major Holdings
25th Jul 20257:00 amRNSBoard Change
24th Jul 202511:02 amRNSAnnual Results for the year ended 31 March 2025
18th Jul 20259:03 amRNSTR1: Notification of Major Holdings
25th Jun 20254:17 pmRNSTR1: Notification of Major Holdings
30th May 20257:30 amRNSTR1: Notification of Major Holdings
28th Apr 20257:00 amRNSQuarterly Operating Update
17th Apr 20255:06 pmRNSTR1: Notification of Major Holdings
15th Apr 202511:15 amRNSTR1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.